IDH1 and neoplasm: However, this result should be interpreted with caution, as the data were obtained from 99 treatment‐naive GB prospectively collected by the Clinical Proteomic Tumor Analysis Consortium (CPTAC), 91 of which were IDH‐wildtype GB, but the other eight were IDH‐mutated GB.